HSPD1 and esophageal adenocarcinoma: In addition, hsp60/10 and the ATP synthase β-subunit, together, have been shown to be differentially expressed in breast cancer, null cell pituitary adenoma, Barrett’s esophagus (premalignant condition to esophageal adenocarcinoma), and head and neck squamous cell carcinomas53–56.